• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, April 1, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Understanding immune reaction to the hepatitis B virus

Bioengineer by Bioengineer
February 12, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Professor Hiroyuki Oshiumi

The innate immune system in mammals defends against infection from viruses and other microbial infections. Unfortunately, the human immune response to the hepatitis B virus (HBV) is not yet fully understood. Without vaccination, hepatitis B causes both acute and chronic infections of the liver, and can lead to the development of cirrhosis and liver cancer. To gain a deeper understanding of how the immune system reacts to HBV, researchers from several institutions in Japan and Malaysia led by Professor Hiroyuki Oshiumi of Kumamoto University performed in vivo experiments on the tree shrew, a small mammal that is also prone to HBV infection.

Infection was successful in just over half (55%) of the animals injected with the virus suggesting that a large portion of tree shrews have a natural immunity to HBV. The cytokine interferon-gamma (IFN-gamma), which plays an important role in the activation and modulation of the immune system and in impeding the ability of a virus to replicate, was found early (1 day after infection) in the infected population. This is thought to be caused by the activation of hepatic natural killer (NK) cells in reaction to HBV infection. Further analysis added to the growing body of evidence supporting claims of antiviral actions of IFN-gamma on HBV by confirming that IFN-gamma prompts hepatocyte expression of the DDX60 gene. Expression of this gene causes the degeneration of HBV RNA.

Importantly, the researchers also found that extracellular vesicles (EV) are integral to the innate immune response to HBV infection. "We showed that EVs coming from HBV-infected hepatocytes carry viral nucleic acids which, in turn, stimulates the innate immune response against HBV," said Professor Oshiumi. "However, we also found that HBV can escape the immune response by increasing the immunosuppressive microRNA levels in exosomes. The increase of these microRNAs eventually results in a reduction of NK cell activation which allows HBV to easily proliferate."

The results of this research opens a new window into the innate immune response to the hepatitis B virus and provides further insight into the molecular mechanisms involved. The full article can be found online in the open-access journal Frontiers in Immunology.

###

[Citation]

T. Kouwaki, Y. Fukushima, T. Daito, T. Sanada, N. Yamamoto, E. J. Mifsud, C. R. Leong, K. Tsukiyama-Kohara, M. Kohara, M. Matsumoto, T. Seya, and H. Oshiumi, "Extracellular vesicles including exosomes regulate innate immune responses to hepatitis B virus infection," Frontiers in Immunology, vol. 7, p. 335, Aug 2016.
DOI: 10.3389/fimmu.2016.00335

Media Contact

J. Sanderson, N. Fukuda
[email protected]

http://ewww.kumamoto-u.ac.jp/en/news/

Share13Tweet8Share2ShareShareShare2

Related Posts

Johns Hopkins Team Develops Nasal DNA Vaccine as New Therapeutic Approach for Tuberculosis

April 1, 2026

Magneto-Acoustic Stimulation Boosts Brain Function in Parkinson’s

April 1, 2026

Frailty Index Linked to Strength, Biochemical Markers

April 1, 2026

Fluorothiazinone Suppresses Burkholderia Lung Infection

April 1, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1006 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    43 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Kennesaw State University Launches AI-Powered Chatbot Project to Train Educators

Long-Term Swine Study Reveals Health Benefits of Natural Compounds: Oregano, Rosemary, and Thyme

Targeted Therapies Enhance Long-Term Survival in Lung Cancer Patients with Rare Genetic Mutations

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.